Breaking: Vinay Prasad departs the FDA

Marty Makary's top deputy is out after less than three months.

Log In    Subscribe BREAKING NEWS   Vinay Prasad departs the FDA By Lizzy Lawrence, Adam Feuerstein, Matthew Herper Courtesy FDA Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial decisions about a treatment for boys with Duchenne muscular dystrophy. READ MORE Sign up for the Readout Your morning rundown of the science, politics, and money driving biotech today. Learn more. In Case You Missed It 1   FDA permits use of Sarepta Therapeutics' Duchenne therapy in younger patients after short-lived halt By Adam Feuerstein 2   Did a drug prevent this man's ALS? By Jason Mast 3   Replimune skin cancer therapy rejected by FDA, a sign of regulators' hardened stance By Adam Feuerstein 4   New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment By Andrew Joseph Don't miss out on another STAT investigation Unlock the world of health and medicine with a subscription to STAT+ Learn more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us